Philippe Moreillon

Author PubWeight™ 75.69‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J 2009 11.90
2 Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med 2009 7.82
3 Fibrinogen and fibronectin binding cooperate for valve infection and invasion in Staphylococcus aureus experimental endocarditis. J Exp Med 2005 1.85
4 Infective endocarditis. Nat Rev Cardiol 2011 1.77
5 Genetic diversity and ecological success of Staphylococcus aureus strains colonizing humans. Appl Environ Microbiol 2008 1.58
6 The discriminatory power of MALDI-TOF mass spectrometry to differentiate between isogenic teicoplanin-susceptible and teicoplanin-resistant strains of methicillin-resistant Staphylococcus aureus. FEMS Microbiol Lett 2006 1.29
7 In vitro prevention of the emergence of daptomycin resistance in Staphylococcus aureus and enterococci following combination with amoxicillin/clavulanic acid or ampicillin. Int J Antimicrob Agents 2010 1.26
8 Granular layer in the periplasmic space of gram-positive bacteria and fine structures of Enterococcus gallinarum and Streptococcus gordonii septa revealed by cryo-electron microscopy of vitreous sections. J Bacteriol 2006 1.19
9 Prospective monitoring of cefepime in intensive care unit adult patients. Crit Care 2010 1.18
10 Innate sensors for Gram-positive bacteria. Curr Opin Immunol 2003 1.15
11 Comparative analysis of the roles of HtrA-like surface proteases in two virulent Staphylococcus aureus strains. Infect Immun 2005 1.12
12 Clinical consensus conference: survey on Gram-positive bloodstream infections with a focus on Staphylococcus aureus. Clin Infect Dis 2009 1.09
13 High-dose daptomycin plus fosfomycin is safe and effective in treating methicillin-susceptible and methicillin-resistant Staphylococcus aureus endocarditis. Antimicrob Agents Chemother 2012 1.08
14 Fungicidal synergism of fluconazole and cyclosporine in Candida albicans is not dependent on multidrug efflux transporters encoded by the CDR1, CDR2, CaMDR1, and FLU1 genes. Antimicrob Agents Chemother 2003 1.06
15 Deletion of hypothetical wall teichoic acid ligases in Staphylococcus aureus activates the cell wall stress response. FEMS Microbiol Lett 2012 1.06
16 The fibrinogen- and fibronectin-binding domains of Staphylococcus aureus fibronectin-binding protein A synergistically promote endothelial invasion and experimental endocarditis. Infect Immun 2008 1.05
17 Staphylococcus aureus host range and human-bovine host shift. Appl Environ Microbiol 2011 1.04
18 Beta-lactams against methicillin-resistant Staphylococcus aureus. Curr Opin Pharmacol 2005 1.03
19 Role of sigmaB in the expression of Staphylococcus aureus cell wall adhesins ClfA and FnbA and contribution to infectivity in a rat model of experimental endocarditis. Infect Immun 2005 1.02
20 Experimental and computational approaches to quantitative proteomics: status quo and outlook. J Proteomics 2007 1.01
21 Ecological temporal stability of Staphylococcus aureus nasal carriage. J Clin Microbiol 2010 1.00
22 ANIBAL, stable isotope-based quantitative proteomics by aniline and benzoic acid labeling of amino and carboxylic groups. Mol Cell Proteomics 2007 0.98
23 Molecular characterization of a Streptococcus gallolyticus genomic island encoding a pilus involved in endocarditis. J Infect Dis 2011 0.98
24 Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure. JAMA 2011 0.97
25 Antimicrobial resistance of Staphylococcus aureus strains acquired by pig farmers from pigs. Appl Environ Microbiol 2012 0.97
26 Detection of live and antibiotic-killed bacteria by quantitative real-time PCR of specific fragments of rRNA. Antimicrob Agents Chemother 2006 0.96
27 Efficacy of daptomycin in the treatment of experimental endocarditis due to susceptible and multidrug-resistant enterococci. J Antimicrob Chemother 2006 0.95
28 Fibronectin-binding proteins and clumping factor A in Staphylococcus aureus experimental endocarditis: FnBPA is sufficient to activate human endothelial cells. Thromb Haemost 2007 0.94
29 Mutations in penicillin-binding protein (PBP) genes and in non-PBP genes during selection of penicillin-resistant Streptococcus gordonii. Antimicrob Agents Chemother 2006 0.93
30 Mutational analysis of class A and class B penicillin-binding proteins in Streptococcus gordonii. Antimicrob Agents Chemother 2006 0.92
31 Streptococcus tigurinus is highly virulent in a rat model of experimental endocarditis. Int J Med Microbiol 2013 0.92
32 New concepts in the pathophysiology of infective endocarditis. Curr Infect Dis Rep 2006 0.92
33 M-protein and other intrinsic virulence factors of Streptococcus pyogenes are encoded on an ancient pathogenicity island. BMC Genomics 2009 0.91
34 Bonds between fibronectin and fibronectin-binding proteins on Staphylococcus aureus and Lactococcus lactis. Langmuir 2010 0.91
35 Prospective determination of plasma imipenem concentrations in critically ill children. Antimicrob Agents Chemother 2006 0.90
36 Single-step extraction of fluconazole from plasma by ultra-filtration for the measurement of its free concentration by high performance liquid chromatography. J Pharm Biomed Anal 2002 0.90
37 LB11058, a new cephalosporin with high penicillin-binding protein 2a affinity and activity in experimental endocarditis due to homogeneously methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2004 0.88
38 A stable phage lysin (Cpl-1) dimer with increased antipneumococcal activity and decreased plasma clearance. Int J Antimicrob Agents 2011 0.88
39 Natural variability of in vitro adherence to fibrinogen and fibronectin does not correlate with in vivo infectivity of Staphylococcus aureus. Infect Immun 2010 0.87
40 Link between genotype and antimicrobial resistance in bovine mastitis-related Staphylococcus aureus strains, determined by comparing Swiss and French isolates from the Rhône Valley. Appl Environ Microbiol 2011 0.87
41 Proteomic and transcriptomic profiling of Staphylococcus aureus surface LPXTG-proteins: correlation with agr genotypes and adherence phenotypes. Mol Cell Proteomics 2012 0.87
42 Use of a human-like low-grade bacteremia model of experimental endocarditis to study the role of Staphylococcus aureus adhesins and platelet aggregation in early endocarditis. Infect Immun 2012 0.87
43 Human-to-bovine jump of Staphylococcus aureus CC8 is associated with the loss of a β-hemolysin converting prophage and the acquisition of a new staphylococcal cassette chromosome. PLoS One 2013 0.86
44 Pitfalls in cefepime titration from human plasma: plasma- and temperature-related drug degradation in vitro. Antimicrob Agents Chemother 2002 0.86
45 Penicillin-binding protein gene alterations in Streptococcus uberis isolates presenting decreased susceptibility to penicillin. Antimicrob Agents Chemother 2010 0.85
46 Development of glycopeptide-intermediate resistance by Staphylococcus aureus leads to attenuated infectivity in a rat model of endocarditis. Microb Pathog 2008 0.84
47 Efficacy of garenoxacin in treatment of experimental endocarditis due to Staphylococcus aureus or viridans group streptococci. Antimicrob Agents Chemother 2004 0.83
48 Genometrics as an essential tool for the assembly of whole genome sequences: the example of the chromosome of Bifidobacterium longum NCC2705. BMC Microbiol 2005 0.83
49 Effects of alpha-phosphoglucomutase deficiency on cell wall properties and fitness in Streptococcus gordonii. Microbiology 2007 0.83
50 Promoter and transcription analysis of penicillin-binding protein genes in Streptococcus gordonii. Antimicrob Agents Chemother 2007 0.81
51 In vitro characterization of PlySK1249, a novel phage lysin, and assessment of its antibacterial activity in a mouse model of Streptococcus agalactiae bacteremia. Antimicrob Agents Chemother 2013 0.81
52 Contribution of (sub)domains of Staphylococcus aureus fibronectin-binding protein to the proinflammatory and procoagulant response of human vascular endothelial cells. Thromb Haemost 2009 0.81
53 Structure-function characterization and optimization of a plant-derived antibacterial peptide. Antimicrob Agents Chemother 2005 0.80
54 Infectivity of Lactobacillus rhamnosus and Lactobacillus paracasei isolates in a rat model of experimental endocarditis. J Med Microbiol 2007 0.79
55 In vitro activities of tigecycline combined with other antimicrobials against multiresistant gram-positive and gram-negative pathogens. J Antimicrob Chemother 2007 0.79
56 Lack of in vitro biofilm formation does not attenuate the virulence of Streptococcus gordonii in experimental endocarditis. FEMS Immunol Med Microbiol 2006 0.79
57 Evidence for a new post-translational modification in Staphylococcus aureus: hydroxymethylation of asparagine and glutamine. J Proteomics 2011 0.77
58 Combining protein identification and quantification: C-terminal isotope-coded tagging using sulfanilic acid. Rapid Commun Mass Spectrom 2006 0.77
59 PEGylating a bacteriophage endolysin inhibits its bactericidal activity. AMB Express 2011 0.77
60 Bactericidal synergism between daptomycin and the phage lysin Cpl-1 in a mouse model of pneumococcal bacteraemia. Int J Antimicrob Agents 2013 0.75
61 Fitness cost and impaired survival in penicillin-resistant Streptococcus gordonii isolates selected in the laboratory. Antimicrob Agents Chemother 2007 0.75
62 Efficacy of iclaprim against wild-type and thymidine kinase-deficient methicillin-resistant Staphylococcus aureus isolates in an in vitro fibrin clot model. Antimicrob Agents Chemother 2009 0.75
63 [Infective endocarditis: update]. Rev Med Suisse Romande 2004 0.75
64 Daptomycin for highly resistant Enterococcus faecium infection. Swiss Med Wkly 2012 0.75